The deal is Merck’s largest since 2015, when it spent $17bn on acquiring Sigma-Aldrich, also a life sciences specialist.

Inductive's global ADMET prediction models are now available as a connector for Claude, enabling any drug discovery scientist working with Claude to access state-of-the-art predictive models directly ...

AI drug discovery cleared its first Phase IIa clinical test in 2025, as BIO 2026 confirmed the shift from speculation to ...

A German company that provides products and services that accelerate drug development and manufacturing is set to acquire the ...

Merck KGaA, Darmstadt, Germany, has agreed to acquire Bio-Techne for approximately $11.3 billion, the companies said today, in a deal designed to position the buyer as more of a leader across the life ...

A groundbreaking advancement in technology has emerged: scientists have developed a bio-computer using human cells. This ...

Merck KGaA, Darmstadt, Germany, a leading science and technology company, and Bio-Techne Corporation, a Minneapolis-based ...

Wheeler Bio, an Oklahoma-based Contract Development and Manufacturing Organization (CDMO) specializing in antibody-based therapeutics, today announced the launch of its redesigned website, showcasing ...

In collaboration with InvestHK and HKTDC, HKSTP led a delegation of 41 park companies, institutes and spin-offs from five renowned local universities to showcase the Hong Kong’s life and health ...

Dr. Hubert Scholze, Chief Business Officer, Rezon Bio. As a member of Rezon Bio’s Executive Leadership Team, Dr. Hubert ...

Sofinnova Partners, a leading European life sciences venture capital firm, today announced that its portfolio company Myricx Bio (“Myricx”) has reached agreement to be acquired by Novartis, for up to ...

Financing follows Torres's CrossBridge Bio acquisition by Eli Lilly and supports translation of ARTAN Bio's programmable approach to mutation-driven aging biology. ST. PETERSBURG, ...